Abstract The Japanese Society of Chemotherapy (JSC) conducted the fi rst nationwide surveillance of bacterial respiratory pathogens during the period from January to August 2006. With the cooperation of 32 medical institutions throughout Japan, a total of 924 strains belonging to seven clinically relevant bacterial species were collected from adult patients with well-diagnosed respiratory tract infections (RTIs (CLSI). The antibacterial agents employed were 25 β-lactams, three aminoglycosides, four macrolides (including one azalide and one ketolide), one lincosamide, one tetracycline, two glycopeptides, fi ve fl uoroquinolones, and one oxazolidinone. The incidence of methicillin-resistant S. aureus (MRSA) was 63.4%, and the incidences of penicillin-intermediately resistant S. pneumoniae (PISP) and penicillin-resistant S. pneumoniae (PRSP) were 35.0% and 4.0%, respectively. Among H. infl uenzae, 21.2% of the strains were found to be β-lactamase-nonproducing ampicillin (ABPC)-intermediately resistant (BLNAI), 29.1% to be β-lactamase-nonproducing ABPC-resistant (BLNAR), and 4.8% to be β-lactamaseproducing ABPC-resistant (BLPAR) strains. The incidence of extended-spectrum β-lactamase-producing K. pneumoniae was 2.7% (2 of 74 strains). Three (2.1%) of the 143 P. aeruginosa strains were found to be metallo-β-lactamaseproducing, including 1 (0.7%) multidrug-resistant strain. Through the nationwide surveillance, we obtained fundamental antimicrobial susceptibility data of clinically relevant bacterial pathogens in adult RTI to various antibacterial agents. These data will be a useful reference for future periodic surveillance studies, as well as for investigations to control antimicrobial-resistant pathogens.
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Introduction
In order to investigate trends in the isolation of various bacterial pathogens and the emergence of antimicrobial resistance in these pathogens, the Japanese Society of Chemotherapy (JSC) established a nationwide surveillance network in 2006. The fi rst survey was conducted during the period from January to August 2006, with the cooperation of 32 medical institutions throughout Japan.
To keep the quality of surveillance high, the collection of bacterial strains was limited to clinically relevant species, i.e., Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus infl uenzae, Moraxella catarrhalis, Klebsiella pneumoniae, and Pseudomonas aeruginosa and to those isolated as causative bacteria from adult patients with well-diagnosed respiratory tract infections (RTIs). The incidence of these bacteria and their susceptibility to panels of antibacterial agents were analyzed according to stratifi cations in various clinical settings.
Here we report, for the fi rst time, the current bacterial species that cause RTI in adults and the trends in resistance to existing antibacterial agents, elucidated by the JSCconducted nationwide surveillance. These results obtained from this surveillance will be used as a set of controls for surveillance studies conducted in the future by the JSC and by other organizations as well.
Materials and methods

Strains and quality control
The causative bacteria of well-diagnosed adult RTI 1 were isolated from sputum and from specimens of trans-tracheal aspiration or bronchoscopy, and their causality was confi rmed 1 by quantitative culture, Gram staining, and observation of phagocytes, and/or by other means at the 32 medical institutions listed in Table 1 . These bacteria were identifi ed at the species level, suspended in the preservation broth
